2020

30.03.2020 – Rapid Nutrition PLC

Rapid Nutrition PLC: Half Year Results - Well Ahead of Expectations

Rapid Nutrition PLC / Key word(s): Half Year Results
Rapid Nutrition PLC: Half Year Results - Well Ahead of Expectations

30.03.2020 / 07:00

---------------------------------------------------------------------------

30th March, 2020

Rapid Nutrition Plc

("Rapid", the "Company" or the "Group")

Half Year Results - Well Ahead of Expectations

Rapid Nutrition (RAP:SW, RPNRF:OTC), a natural healthcare company focused on
the research and development, manufacture and distribution of weight-loss
and diet management products, sports nutrition products, vitamins and
dietary supplements, and a range of life science products, is pleased to
announce its H1 results.

In unprecedented times, health is of the utmost importance and the Group is
well positioned to leverage changing purchase patterns as a result of
concerted efforts to expand its online presence. Health-related products
have never been in higher demand and the Board firmly believes a significant
behavioural shift is imminent as consumers become even more
health-conscious.

The first half of the new financial year 2020 has begun strongly and trading
is in line with the Company's expectations. In particular, the Group has
delivered strong operational performance as recently announced on 14th
January, with H1 revenues of $1.78m (H1 FY2019: $0.78m) in the period under
review, and continues to progress its strategy of bringing to market new
products, across multiple categories, which it believes will anchor future
earnings.

Recent Operational Developments

Rapid Nutrition is pleased to announce recent highlights including:

- The Group's key partnerships and distribution agreements in numerous
countries, notably the United States and Australia, which are continuing to
develop this year

- The successful rollout of SystemLS across 500 GNC corporate stores and
online (gnc.com)

- Sigma's rollout of the Group's product portfolio across 100 pharmacy
stores

- The Group's rollout of its product portfolio through leading health food
chain Mr Vitamins

- The successful completion of a non-brokered placement of EUR 240,000 led
by Swiss Asset Manager, reaffirming the positive sentiment building in the
institutional investor community, as well as the Group's ongoing commitment
to building long-term shareholder value

- Last quarter's Annual General Meeting in Australia which saw overwhelming
shareholder support, resulting in all resolutions being passed

The Group also continues to ensure that it is well positioned for the
future:

- The Group continues to expand its global distribution footprint and has
entered into discussions with innovative companies in key markets such as
Switzerland, Brazil and Africa.

- The Group's Direct to Consumer channel through its partnership with
Streamcast Marketing is anticipated to expand considerably this year with a
major brand launch of SystemLS scheduled this quarter, aimed at driving
additional revenues and increased margins in the second half of the
financial year.

- Rapid Nutrition's global logistics partner Super Health Center ("SHC") has
presented the Group's flagship brand to key retailers and distribution
partners in the UK and the Middle East with in-market visits which have
received uniformly positive responses and created expectations of additional
incremental revenues for the Group in H2.

- As the Group's product offering continues to expand with innovative
formulas in popular categories such as CBD and Antiviral Immunity, it is
also looking to expand into new distribution channels in Australia this
quarter through high-end retailers, offering a true 360-degree marketing
approach for its products across multiple platforms.

Rapid Nutrition CEO, Simon St. Ledger stated, "The Board believes there are
significant opportunities to grow the business organically and through
acquisitions. Our focus in FY2020 will be based around these initiatives to
generate further growth over the long term."

The Group's half year report will be published on March 30th, 2020.

About Rapid Nutrition
Rapid Nutrition is a natural healthcare company focused on the research,
development and production of a range of life science products. The company
was established based on its successful and proven weight-loss supplement
range which is exported worldwide and now offers consumers a growing range
of health and wellbeing solutions to meet existing and emerging societal
health concerns, as well as a providing number of wider services to the life
sciences industry. For more information, please visit Rapid Nutrition PLC

Investor Relations Contact:
ir@rnplc.com

Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995 that involve risks, uncertainties and assumptions that could cause
Rapid Nutrition PLCs actual results and experience to differ materially from
anticipated results and expectations expressed in these forward-looking
statements. Rapid Nutrition PLC has in some cases identified forward-looking
statements by using words such as "anticipates," "believes," "hopes,"
"estimates," "looks," "expects," "plans," "intends," "goal," "potential,"
"may," "suggest," and similar expressions. Rapid PLC undertakes no
obligation to release publicly the results of any revisions to any such
forward-looking statements that may be made to reflect events or
circumstances after the date of this press release or to reflect the
occurrence of unanticipated events, except as required by applicable law or
regulation.

Disclosure Requirement:
This media information does not constitute an offer to sell, or a
solicitation of an offer to buy, any securities. This information does not
constitute an offering prospectus within the meaning of article 652a or
article 1156 of the Swiss Code of Obligations or a listing prospectus within
the meaning of the listing rules of the SIX Swiss Exchange. The media
release is in accordance with International Reporting Standard: Rule
12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits
non-U.S. companies with securities listed primarily on a Qualified Foreign
Exchange to make publicly available to U.S investors in English the same
information that is made publicly available in their home countries as an
alternative to SEC reporting Exchange Act Rule 12g3-2(b).


close